These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 25888371)

  • 1. Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.
    Liu Y; He YT; Tan N; Chen JY; Liu YH; Yang DH; Huang SJ; Ye P; Li HL; Ran P; Duan CY; Chen SQ; Zhou YL; Chen PY
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH; Jiang L; Chen JY; Tan N; Liu Y; He PC
    Int Urol Nephrol; 2016 Oct; 48(10):1675-82. PubMed ID: 27473154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention.
    Lin KY; Wu ZY; You ZB; Zheng WP; Lin CJ; Jiang H; Ruan JM; Guo YS; Zhu PL
    Int Heart J; 2018 Sep; 59(5):926-934. PubMed ID: 30158378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study.
    Wang K; Li HL; Chen LL; Bei WJ; Lin KY; Smyth B; Chen SQ; Guo XS; Guo W; Liu YH; Chen PY; Chen JY; Chen KH; Liu Y; Tan N
    Medicine (Baltimore); 2017 Mar; 96(10):e6259. PubMed ID: 28272231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of N-terminal pro-B-type natriuretic peptide with contrast-induced nephropathy and long-term outcomes in patients with chronic kidney disease and relative preserved left ventricular function.
    Liu YH; Liu Y; Zhou YL; Yu DQ; He PC; Xie NJ; Li HL; Wei-Guo ; Chen JY; Tan N
    Medicine (Baltimore); 2015 Apr; 94(13):e358. PubMed ID: 25837748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Contrast-Induced Nephropathy Non-Recovery and Poor Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
    Luo M; Zhu Z; Zhang L; Zhang S; You Z; Chen H; Rao J; Lin K; Guo Y
    Circ J; 2023 Jan; 87(2):258-265. PubMed ID: 36288935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS
    Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
    Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P
    Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Duran M; Yarlioglues M; Murat SN; Demircelik MB; Ergun G; Acikgoz SK; Sensoy B; Cetin M; Ornek E
    Clin Cardiol; 2014 Aug; 37(8):485-92. PubMed ID: 24805995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mehran contrast nephropathy risk score: Is it still useful 10 years later?
    Abellás-Sequeiros RA; Raposeiras-Roubín S; Abu-Assi E; González-Salvado V; Iglesias-Álvarez D; Redondo-Diéguez A; González-Ferreiro R; Ocaranza-Sánchez R; Peña-Gil C; García-Acuña JM; González-Juanatey JR
    J Cardiol; 2016 Mar; 67(3):262-7. PubMed ID: 26169247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
    Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
    J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
    Kragelund C; Grønning B; Omland T; Køber L; Strande S; Steffensen R; Hildebrandt P
    Am Heart J; 2006 Mar; 151(3):712.e1-712.e7. PubMed ID: 16504637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
    Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
    Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.